ArticleCureus2025
Vaginal Resection of a Large Nascent Uterine Pyomyoma Following Late Miscarriage.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine myomas are common benign tumors in women of reproductive age and may undergo degenerative changes during or after pregnancy. In rare cases, rapid growth and necrosis can complicate the clinical course and pose significant risks for infection and fertility. We report the case of a 29-year-old nulliparous woman who presented two months after a late miscarriage at 15 weeks of gestation with severe abdominal pain and a necrotizing uterine fibroid. Imaging revealed a large type 2 myoma, initially classified as type 3, according to the International Federation of Gynecology and Obstetrics (FIGO) classification, with central necrosis, prolapsing through the cervix into the vagina. Despite broad-spectrum antibiotics, symptoms persisted, and inflammatory markers increased. A fertility-preserving vaginal myomectomy was performed, allowing complete removal of a 120 mm necrotic fibroid. Postoperative recovery was uneventful, and follow-up imaging at three months showed only a small stable intramural remnant. The uterine cavity appeared normal on hysteroscopy, and the patient remained asymptomatic. Necrotizing fibroids following miscarriage pose diagnostic and therapeutic challenges. Magnetic resonance imaging (MRI) provides essential information for surgical planning, and vaginal myomectomy can be a fertility-preserving alternative when the fibroid becomes nascent. This case illustrates that even FIGO type 3 fibroids can be effectively managed by vaginal myomectomy. The myoma may convert to a FIGO type 2 myoma under pregnancy-related hormonal stimulation and subsequent necrosis, and may become infected, forming a "pyomyoma nascent." In selected patients, this approach enables rapid infection control, avoids hysterectomy, and preserves fertility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.